Last Update Time:
19-Mar-2025 16:00:00
ISIN:
INE437A01024
Sector:
Healthcare
Symbol:
APOLLOHOSP
Apollo Hospitals Enterprise Limited
₹6,430.00
₹183.20
(2.93%)
▲
Prev. Close
₹6,246.80
Open
₹6,275.25
Close
₹6,427.55
Range
₹6,108.50 - ₹6,751.50
High
₹6,434.90
Low
₹6,227.10
Ind. Close
₹0.00
VWAP
₹6,388.75
The current stock price of Apollo Hospitals Enterprise Limited is ₹6,430.00, with a target price range between ₹6,108.50 and ₹6,751.50. The stock has experienced a price change of ₹183.20 (2.93%), reflecting recent market volatility.
Today's opening price was ₹6,275.25, while the previous close stood at ₹6,246.80.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Apollo Hospitals Enterprise Limited Price Chart
Apollo Hospitals Enterprise Limited Pre Open Market Overview: 19-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 6275.25
- Previous Close Price: 6246.8
- Change: 28.45%
- Total Traded Volume: 702
- Total Buy Quantity: 1,765
- Total Sell Quantity: 2,215
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 6,242.80 | 1.00 | 0.00 |
| 6,246.80 | 30.00 | 0.00 |
| 6,250.00 | 3.00 | 0.00 |
| 6,250.10 | 1.00 | 0.00 |
| 6,260.00 | 1.00 | 0.00 |
| 6,275.25 | 0.00 | 73.00 |
| 6,278.05 | 0.00 | 398.00 |
| 6,279.80 | 0.00 | 10.00 |
| 6,280.00 | 0.00 | 1.00 |
| 6,289.80 | 0.00 | 10.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 1765
Total Sell Quantity: 2215
Shareholding Patterns of Apollo Hospitals Enterprise Limited
Key Trade Statistics of Apollo Hospitals Enterprise Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 5.80 |
| Traded Value (₹ Cr.) | 370.47 |
| Total Market Cap (₹ Cr.) | 92,453.53 |
| Free Float Market Cap (₹ Cr.) | 65,011.48 |
| Impact cost | 0.02 |
| Quantity Traded | 579,880.00 |
| Deliverable Quantity | 398,197.00 |
| % of Quantity to Traded | 68.67 |
| Security VaR | 9.29 |
| Index VaR | N/A |
| VaR Margin | 9.29 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 12.79 |
| Face Value | 5 |
Key Price Statistics of Apollo Hospitals Enterprise Limited
The 52-week high for Apollo Hospitals Enterprise Limited was ₹7,545.35, recorded on 07-Jan-2025. On the other hand, the 52-week low stands at ₹5,693.20, with the lowest value recorded on 04-Jun-2024.
The upper band for trading is ₹6,871.45, and the lower band is ₹5,622.15. The price band is No Band%.
The stock's daily volatility stands at 1.48, while the annualized volatility is 28.28. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (07-Jan-2025) | 7,545.35 |
| 52 Week Low (04-Jun-2024) | 5,693.20 |
| Upper Band | 6,871.45 |
| Lower Band | 5,622.15 |
| Price Band (%) | No Band |
| Daily Volatility | 1.48 |
| Annualised Volatility | 28.28 |
| Tick Size | 0.05 |
Key Securities Statistics of Apollo Hospitals Enterprise Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 10-Jan-1996 |
| Adjusted P/E | 68.15 |
| Symbol P/E | 68.15 |
| Index | NIFTY 50 |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Basic Industry | Hospital |
Security Status of Apollo Hospitals Enterprise Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Apollo Hospitals Enterprise Limited
| Subject | Date |
|---|---|
| General Updates | 14-Mar-2025 |
| Press Release (Revised) | 04-Mar-2025 |
| Capacity addition | 04-Mar-2025 |
| Press Release | 04-Mar-2025 |
| Capacity addition | 04-Mar-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 14-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 12-Feb-2025 |
| Record Date | 10-Feb-2025 |
Corporate Actions of Apollo Hospitals Enterprise Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 5 | Interim Dividend - Rs 9 Per Share | 14-Feb-2025 |
| 5 | Annual General Meeting/Dividend - Rs 10 Per Share | 16-Aug-2024 |
| 5 | Interim Dividend - Rs 6 Per Share | 20-Feb-2024 |
| 5 | Annual General Meeting/Dividend - Rs 9 Per Share | 18-Aug-2023 |
| 5 | Interim Dividend - Rs 6 Per Share | 24-Feb-2023 |
| 5 | Annual General Meeting/Dividend - Rs 11.75 Per Share | 18-Aug-2022 |
| 5 | Annual General Meeting/Dividend - Rs 3 Per Share | 18-Aug-2021 |
| 5 | Annual General Meeting/Dividend - Rs 2.75 Per Share | 17-Sep-2020 |
| 5 | Interim Dividend - Rs 3.25 Per Share | 25-Feb-2020 |
| 5 | Annual General Meeting/Dividend - Rs 6 Per Share | 12-Sep-2019 |
| 5 | Annual General Meeting/Dividend- Rs 5 Per Share | 12-Sep-2018 |
| 5 | Annual General Meeting/Dividend - Rs 6/- Per Share | 07-Sep-2017 |
| 5 | Interim Dividend - Rs 6/- Per Share (Purpose Revised) | 22-Mar-2016 |
| 5 | Annual General Meeting/Dividend Rs 5.75 Per Share | 30-Jul-2015 |
| 5 | Annual General Meeting And Dividend Rs.5.75 Per Share | 13-Aug-2014 |
| 5 | Annual General Meeting And Dividend Rs.5.50 Per Share | 25-Jul-2013 |
| 5 | Annual General Meeting/Dividend Rs 4 Per Share | 26-Jul-2012 |
| 5 | Annual General Meeting And Dividend Rs.3.75 Per Share | 07-Jul-2011 |
| 5 | Face Value Split From Rs.10/- To Rs.5/- | 02-Sep-2010 |
| 5 | Annual General Meeting And Dividend Rs.7/- Per Share | 15-Jul-2010 |
Board Meetings of Apollo Hospitals Enterprise Limited
Financial Results of Apollo Hospitals Enterprise Limited
Company Directory of Apollo Hospitals Enterprise Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.apollohospitals.com | Head Office/ Corporate Office | Ali Towers, III Floor, No.55, Greams Road, | CHENNAI |
| www.apollohospitals.com | Registered Office | 19, Bishop Gardens, Raja Annamalaipuram, | CHENNAI |
| www.apollohospitals.com | Transfer Agent | M/s. Integrated Enterprises (India) Limited 2nd Floor, Kences Towers, 1, Ramakrishna Street, North Usman Road, T.Nagar | CHENNAI |
Insider Trading of Apollo Hospitals Enterprise Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | SUNEETA REDDY | 245400000 | Pledge |
| 7(2) | SUNEETA REDDY | 245400000 | Pledge Revoke |
| 7(2) | SUNEETA REDDY | 2170000000 | Pledge |
| 7(2) | SUNEETA REDDY | 5460900000 | Pledge Revoke |
| 7(2) | SUNEETA REDDY | 2123000000 | Pledge |
| 7(2) | SUNEETA REDDY | 559100000 | Pledge Revoke |
| 7(2) | SUNEETA REDDY | 1671900000 | Pledge Revoke |
| 7(2) | SUNEETA REDDY | 4260900000 | Pledge Revoke |
| 7(2) | SUNEETA REDDY | 1331400000 | Pledge Revoke |
| 7(2) | SUNEETA REDDY | 1329900000 | Pledge |
| 7(2) | SUNEETA REDDY | 1341500000 | Pledge Revoke |
| 7(2) | SUNEETA REDDY | 1353300000 | Pledge |
| 7(2) | K VISHWESHWAR REDDY | 263300000 | Pledge Revoke |
| 7(2) | K VISHWESHWAR REDDY | 263300000 | Pledge |
| 7(2) | K VISHWESHWAR REDDY | 442600000 | Pledge |
| 7(2) | K VISHWESHWAR REDDY | 432800000 | Pledge Revoke |
| 7(2) | PCR INVESTMENTS LIMITED | 2944200000 | Pledge |
| 7(2) | PCR INVESTMENTS LIMITED | 2984300000 | Pledge Revoke |
| 7(2) | SUNEETA REDDY | 1313300000 | Pledge Revoke |
| 7(2) | SUNEETA REDDY | 1313300000 | Pledge |
Annual Reports of Apollo Hospitals Enterprise Limited
Investor Complaints of Apollo Hospitals Enterprise Limited
Event Calendar of Apollo Hospitals Enterprise Limited
| Purpose | Details |
|---|---|
| Results/Dividend/Stock-split | The Company had informed the Exchange regarding a Board Meeting to be held on May 28, 2010 to consider inter alia :- (1)The Audited Financial Results of the Company for the year ended March 31, 2010; (2) The Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended March 31, 2010; (3) To recommend a dividend, if any, for the financial year ended March 31, 2010. The Company has now informed the Exchange that the Company at its Board Meeting to be held on May 28, 2010 will also consider and approve sub-division (Spilt) of equity shares of the Company and other matters connected therewith. (Purpose Revised). |
| Results/Dividend | To consider inter alia:- (1)The Audited Financial Results of the Company for the year ended March 31, 2010. (2) The Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended March 31, 2010. (3) To recommend a dividend, if any, for the financial year ended March 31, 2010. |
| Results/Others | The Company had informed the Exchange that the meeting of Board of Directors of the Company is scheduled to be held on August 12, 2010 inter alia, to consider, approve and take on record the unaudited financial results of the Company for the quarter ended June 30, 2010. The Company has now informed the Exchange that one of the items in the agenda for the Board Meeting scheduled to be held on August 12, 2010 is to consider and approve fixing the record date, to determine the eligible shareholders of the company, to receive the sub-divided equity shares of face value of Rs.5/- each in the place of existing equity shares of face value of Rs.10/- each. (Purpose Revised) |
| Results/Dividend | to consider inter alia :- (1)The Audited Financial Results of the Company for the year ended March 31, 2011; (2) The Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended March 31, 2011; (3) To recommend a dividend, if any, for the financial year ended March 31, 2011. |
| Results/Dividend | To consider inter alia :- (1) The Audited Financial Results of the Company for the year ended March 31, 2012; (2) The Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended March 31, 2012; (3) To recommend a dividend, if any, for the financial year ended March 31, 2012. |
| Results/Dividend | To consider inter alia :- (1) the Audited Financial Results of the Company for the quarter/year ended March 31, 2013; (2) the Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended March 31, 2013; (3) to recommend a dividend, if any, for the financial year ended March 31, 2013. |
| Results | To consider inter alia, approve and take on record unaudited financial results of the Company for the quarter ended June 30, 2013. |
| Results | To consider inter alia, approve and take on record unaudited financial results of the Company for the quarter/half year ended September 30, 2013. |
| Results | To consider inter alia, approve and take on record unaudited financial results of the Company for the quarter/nine months ended December 31, 2013. |
| Results/Dividend | To consider inter alia:- (i) The Audited Financial Results of the Company for the quarter/year ended 31st March 2014. (ii) The Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended 31st March 2014. (iii) To recommend a dividend, if any, for the financial year ended 31st March 2014. The Trading Window for dealing in the Company's securities shall remain closed from May 18, 2014 to May 29, 2014 (both days inclusive). "The company has provided details of trading window period as per Prohibition of Insider Trading Regulations, 1992 issued by SEBI wherein when the trading window is closed, the employees/directors shall not trade in the company s securities in such period". |
| Results | to consider inter alia, approve and take on record unaudited financial results of the Company for the quarter ended June 30, 2014. The Trading Window for dealing in the Company's securities shall remain closed from August 2, 2014 to August 13, 2014 (both days inclusive). |
| Results | To consider inter alia, approve and take on record, unaudited financial results of the Company for the quarter/half year ended September 30, 2014. |
| Results | To consider inter alia, approve and take on record, unaudited financial results of the Company for the quarter/nine months ended December 31, 2014. |
| Results/Others | To consider inter alia and approve :- (i) The Audited Financial Results of the Company for the quarter/year ended March 31, 2015. (ii) The Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended March 31, 2015. (iii) To recommend a dividend, if any, for the financial year ended March 31, 2015. |
| Results | To consider inter alia, approve and take on record, unaudited financial results of the Company for the quarter/Half year ended September 30, 2015. |
| Results | To consider inter alia, approve and take on record, unaudited financial results of the Company for the quarter and nine months ended December 31, 2015. |
| Dividend | inter alia to consider and approve declaration of interim dividend, if any, for the financial year 2015-2016. |
| Results | To consider inter alia, and approve :1. Standalone audited financial results of the Company for the quarter/year ended March 31, 2016. 2. Consolidated audited financial results of the Company for the year ended March 31, 2016. |
| Results | To consider inter alia, approve and take on record, unaudited financial results of the Company for the quarter ended June 30, 2016 along with the limited review report of the auditors for the corresponding period. |
| Others | inter alia to consider and approve the issue of rated, listed, secured Redeemable Non-Convertible Debentures on a private placement basis to be listed on the wholesale debt market segment of the National Stock Exchange of India Limited. |
| Issue of Securities | Further to our earlier announcement, the Debenture Allotment Committee is scheduled on 7th October 2016 to consider and approve the allotment of 3000 Secured Redeemable Non Convertible Debentures of Rs. 10 lakhs each aggregating to Rs. 300 crores. |
| Issue of Securities | inter alia to consider and approve the allotment of 3000 secured Redeemable Non-Convertible Debentures of face value of Rs. 10 lakhs each aggregating to Rs. 300 crores to Institutional Investors/Banks/Financial Institutions on a private placement basis. |
| Results | to consider inter alia, approve and take on record, unaudited financial results of the Company for the quarter and half year ended September 30, 2016 along with the limited review report of the auditors for the corresponding period. The Trading Window for dealing in the Company s securities shall remain closed from November 1, 2016 to November 13, 2016 (both days inclusive). |
| Results | To consider inter alia, approve and take on record, unaudited financial results of the Company for the quarter and nine months ended December 31, 2016 along with the limited review report of the auditors for the corresponding period. |
| Results/Others | The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held February 14, 2017 o consider inter alia, approve and take on record, unaudited financial results of the Company for the quarter and nine months ended December 31, 2016 along with the limited review report of the auditors for the corresponding period. The Company has now informed the Exchange that aforesaid Board meeting also inter alia, would be to consider and approve the issue of rated, listed, secured Redeemable Non-Convertible Debentures of face value of Rs. 10 lakhs each aggregating to Rs. 200 crores on a private placement basis, to be listed on the wholesale debt market segment of the National Stock Exchange of India Limited. (purpose Revised) |
| Results/Dividend | To consider inter alia, and approve :- (i) Standalone audited financial results of the Company for the quarter / year ended March 31, 2017. (ii) Consolidated audited financial results of the Company for the year ended March 31, 2017. (iii) To recommend a dividend, if any, for the financial year ended March 31,2017. |
| Results | To consider inter alia, approve and take on record, unaudited standalone financial results of the Company for the quarter ended June 30, 2017 along with the limited review report of the auditors for the corresponding period. |
| Results | To consider inter alia, approve and take on record, unaudited standalone financial results of the Company for the quarter and half year ended September 30 2017 along with the limited review report of the auditors for the corresponding period. |
| Results | To consider inter alia, approve and take on record, unaudited financial results of the Company for the quarter and nine months ended December 31, 2017 along with the limited review report of the auditors for the corresponding period. |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the quarter and year ended March 31, 2018, dividend and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2018 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2019 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
| Financial Results/Dividend | The Company had informed the Exchange regarding a Board Meeting Scheduled to be held on February 13, 2020 to consider and approve the financial results for the period ended December 31, 2019. The Company has now informed the Exchange that the aforesaid meeting has also considering declaration of interim dividend for the financial year 2019-2020.( purposed revised) |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Financial Results/Other business matters | APOLLOHOSP : 25-Jun-2020 : The Company has informed the Exchange that a Board meeting to be held on Jun 22, 2020 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on Jun 25, 2020, To consider and approve the financial results for the period ended March 31, 2020 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Fund Raising/Other business matters | To consider Fund Raising and other business matters |
| Fund Raising | To consider and determine the issue price of equity shares to be issued pursuant to QIP |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2020 and other business matters |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2021, dividend and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2021 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2021 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2021 and other business matters |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2023, dividend and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2023 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
| Dividend/Other business matters | To consider dividend and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2023 and other business matters |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2024, dividend and other business matters |
| Other business matters | To consider other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2024 and other business matters |
| Dividend | To consider dividend |
Share Transfers of Apollo Hospitals Enterprise Limited
Voting Results of Apollo Hospitals Enterprise Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 30-AUG-2024 | AGM | To receive consider and adopt:-n(i) The Audited financial statements of the Company for the year ended 31st March 2024, the Reports of the Board Directors and Auditors thereon.n(ii) The audited consolidated financial statements of the Company for the year ended 31st March 2024, together with the Report of the Auditors thereonn |
| 30-AUG-2024 | AGM | Ratification of the remuneration of the Cost Auditor for the year ending 31st March 2025 |
| 30-AUG-2024 | AGM | Extension of benefits of Apollo Hospitals Enterprise Limited Employee Stock Option Plan 2024 to the Eligible Employees of the subsidiary companies, associate companies, joint ventures and group companies of the Company |
| 30-AUG-2024 | AGM | Adoption of Apollo Hospitals Enterprise Limited Employee Stock Option Plan 2024 (Apollo ESOP 2024) |
| 30-AUG-2024 | AGM | Approval to offer or invite subscriptions for secured / unsecured redeemable non-convertible debentures, in one or more series / tranches, aggregating upto ￂ5,000 million on a private placement basis under Sections 42, 71 and other applicable provisions if any of the Companies Act, 2013 read with the Companies (Prospectus and Allotment of Securities) Rules, 2014 and the Companies (Share Capital and Debentures) Rules, 2014. |
| 30-AUG-2024 | AGM | Re-appointment of Dr. Prathap C Reddy as a Whole time Director designated as Executive Chairman for a period of two years. |
| 30-AUG-2024 | AGM | Appoint a Director in place of Smt. Preetha Reddy (DIN 00001871), who retires by rotation and, being eligible, offers herself for re-appointment. |
| 30-AUG-2024 | AGM | Confirmation of payment of Interim Dividend and declaration of final dividend on Equity Shares for the financial year ended March 31, 2024 |
| 17-AUG-2024 | Postal Ballot | Material related party transactions entered into by Apollo Healthco Limited (AHL), anmaterial subsidiary of the Company |
| 17-AUG-2024 | Postal Ballot | Approval for dilution of shareholding in Apollo Healthco Limited (AHL), a materialnsubsidiary of the Company |
| 30-AUG-2023 | AGM | Adoption of audited financial statements (both standalone & consolidated) for the financial year ended 31st March 2023 |
| 30-AUG-2023 | AGM | Ratification of the remuneration of the Cost Auditor for the year ending 31st March 2024. |
| 30-AUG-2023 | AGM | Offer or Invitation to subscribe to Non-Convertible Debentures on a private placement basis |
| 30-AUG-2023 | AGM | Approval for payment of commission to Non-Executive and Independent Directors within the overall ceiling limit of 1% of net profits of the Company for a period of five years with effect from 1st April 2024 |
| 30-AUG-2023 | AGM | Approval for re-appointment of Ms. Velagapudi Kavitha V Dutt as an Independent Director for a further period of five years wef 9th Febraury 2024 |
| 30-AUG-2023 | AGM | Approval for re-appointment of Mr.Mandavilli Bhaskara Nageswara Rao as an Independent Director for a further period of five years wef 9th Febraury 2024 |
| 30-AUG-2023 | AGM | Approval for re-appointment of Dr. Pudugramam Murali Doraiswamy as an Independent Director for a further period of five years wef 27th September 2023 |
| 30-AUG-2023 | AGM | Appoint a Director in place of Smt. Sangita Reddy (DIN 00006285), who retires by rotation and, being eligible, offers herself for re-appointment. |
| 30-AUG-2023 | AGM | confirmation of payment of Interim Dividend and declaration of final dividend on Equity Shares for the financial year ended March 31, 2023 |
| 25-AUG-2022 | AGM | To receive, consider and adopt:-n(i) the audited standalone financial statements of the Company for the year ended March 31, 2022, together with the Reports of the Board of Directors and Auditors thereon, andn(ii) the audited consolidated financial statements of the Company for the year ended March 31, 2022, together with the Report of the Auditors thereon. |
FAQs on Apollo Hospitals Enterprise Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.